{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:34:34Z","timestamp":1793662474434,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pt.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:32:55Z","timestamp":1775129575000},"page":"445-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antimalarial efficacy monitoring after nearly 20 years of artemisinin-based combination therapy in Africa: recalibrating guidance"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7836-1119","authenticated-orcid":false,"given":"Leah F.","family":"Moriarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-9351","authenticated-orcid":false,"given":"Maria M.","family":"Betoulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-9597","authenticated-orcid":false,"given":"Peter","family":"Troell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-3661","authenticated-orcid":false,"given":"Irene","family":"Cavros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6775-1802","authenticated-orcid":false,"given":"Kevin","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-4625","authenticated-orcid":false,"given":"Mateusz M.","family":"Plucinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2026.02.012_bb0005","series-title":"Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery","first-page":"15","article-title":"The history of antimalarial drugs","author":"Meshnick","year":"2001"},{"key":"10.1016\/j.pt.2026.02.012_bb0010","series-title":"Resistance of Malaria Parasites to Drugs: Report of a WHO Scientific Group [Meeting Held in Geneva from 13 to 20 October 1964]","author":"World Health Organization","year":"1965"},{"key":"10.1016\/j.pt.2026.02.012_bb0015","series-title":"Chemotherapy of Malaria: Report of a WHO Scientific Group [Meeting Held in Geneva from 25 April to 1 May 1967]","author":"World Health Organization","year":"1967"},{"key":"10.1016\/j.pt.2026.02.012_bb0020","series-title":"Chemotherapy of Malaria and Resistance to Antimalarials: Report of a WHO Scientific Group [Meeting Held in Geneva from 17 to 24 October 1972]","author":"World Health Organization","year":"1973"},{"key":"10.1016\/j.pt.2026.02.012_bb0025","series-title":"Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.pt.2026.02.012_bb0030","series-title":"Methods for Surveillance of Antimalarial Drug Efficacy","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.pt.2026.02.012_bb0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.02.012_bb0040","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.012_bb0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12936-021-03942-5","article-title":"Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa","volume":"20","author":"Nsanzabana","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.012_bb0050","article-title":"Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settings","author":"White","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.012_bb0055","series-title":"Drug Resistance","article-title":"Multiple first-line therapies as part of the response to antimalarial drug resistance: an implementation guide","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.pt.2026.02.012_bb0060","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1046\/j.1365-3156.2003.01106.x","article-title":"Evaluation of a simple operational approach for monitoring resistance to antimalarial drugs in Peru","volume":"8","author":"Ruebush","year":"2003","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2026.02.012_bb0065","series-title":"USAID President\u2019s Malaria Initiative (PMI) Technical Guidance","author":"USAID","year":"2022"},{"key":"10.1016\/j.pt.2026.02.012_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","article-title":"Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa","volume":"22","author":"Rosenthal","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2026.02.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.101027","article-title":"Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with Southeast Asia: a modelling study","volume":"6","author":"Meier-Scherling","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.pt.2026.02.012_bb0080","series-title":"Strategy to Respond to Antimalarial Drug Resistance in Africa","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.pt.2026.02.012_bb0085","series-title":"Guidelines for the Treatment of Malaria","author":"World Health Organization","year":"2005"},{"key":"10.1016\/j.pt.2026.02.012_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(25)00407-4","volume":"26","author":"Kamya","year":"2026","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.012_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-021-03585-6","article-title":"Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017\u20132018","volume":"20","author":"Gansan\u00e9","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.012_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12936-024-04844-y","article-title":"Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts","volume":"23","author":"Kokori","year":"2024","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.012_bb0105","article-title":"Target product profiles of laboratory and data analytical frameworks for genotyping to monitor antimalarial efficacy","author":"Plucinski","year":"2025","journal-title":"Zenodo"},{"key":"10.1016\/j.pt.2026.02.012_bb0110","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4269\/ajtmh.2003.69.582","article-title":"The impact of repeated malaria attacks on the school performance of children","volume":"69","author":"Fernando","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2026.02.012_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-016-1266-x","article-title":"Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children","volume":"15","author":"Boivin","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.012_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1475-2875-13-S1-P19","article-title":"A comparison of the duration of post-treatment protection of artemether-lumefantrine, dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated malaria","volume":"13","author":"Bretscher","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.012_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12916-022-02265-9","article-title":"Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data","volume":"20","author":"WWARN","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.pt.2026.02.012_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1473-3099(15)00318-7","article-title":"Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial","volume":"16","author":"Sagara","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.012_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12936-019-3089-z","article-title":"In vivo\/ex vivo efficacy of artemether\u2013lumefantrine and artesunate\u2013amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso","volume":"19","author":"Lingani","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.012_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pt.2009.12.007","article-title":"The perils of PCR: can we accurately \u2018correct\u2019 antimalarial trials?","volume":"26","author":"Juliano","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.02.012_bb0145","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00873-21","article-title":"Persistent submicroscopic Plasmodium falciparum parasitemia 72 hours after treatment with artemether-lumefantrine predicts 42-day treatment failure in Mali and Burkina Faso","volume":"65","author":"Beshir","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2026.02.012_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00153-8","article-title":"Genotyping methods to distinguish Plasmodium falciparum recrudescence from new infection for the assessment of antimalarial drug efficacy: an observational, single-centre, comparison study","volume":"5","author":"Schnoz","year":"2024","journal-title":"Lancet Microbe"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492226000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492226000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:07:39Z","timestamp":1780499259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492226000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1471492226000486"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2026.02.012","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimalarial efficacy monitoring after nearly 20 years of artemisinin-based combination therapy in Africa: recalibrating guidance","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}